Laboratories rely on accurate, repeatable and traceable test results to support product quality, regulatory compliance and operational safety. Routine verification of laboratory instruments plays a vital role in maintaining confidence in those results. Stanhope-Seta is pleased to announce the expansion of its UKAS ISO 17034 accreditation, with the addition of five new Certified Reference Materials (CRMs) […]

Purpose-engineered cell-like controls deliver improved positive/negative separation, broad species compatibility, and a liquid, non-biohazardous ready-to-use format EMERYVILLE, Calif. — Slingshot Bio, Inc., a leader in precision cell mimic controls for flow cytometry, today announced the commercial launch of ViaComp® Ultra Amine, a next-generation compensation control designed for amine-reactive viability dyes and fluorophore-conjugated antibody panels in […]

Cognitive biomarker assays inform safety and efficacy decisions by measuring network potentiation and synaptic plasticity Advances the emerging field of organoid intelligence for drug development applications NEW ORLEANS — 28bio today launched CNS-3D Plasticity Organoids, enabling human functional endpoints of learning and memory before drug candidates enter clinical testing. Attrition in neurodegeneration remains among the highest […]

New handheld spectrophotometer will be showcased with digital color workflow solutions at LOUPE Americas and PRINTING United Expo. GRAND RAPIDS, Mich. — X-Rite Pantone, the global authority in color standards and color science, announces eXact™ 2 Basic, the newest addition to the eXact 2 family of portable spectrophotometers. Available now, the new device will be showcased […]

Introducing a new AI approach for accelerated biomarker discovery, demonstrated through Alzheimer’s disease biomarker modeling validated in an independent cohort Basel, Switzerland — Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new AI agent in Genedata Profiler®, its enterprise platform for integrating and analyzing data across […]

ZEISS Spectroscopy has launched ZEISS SPARC (Spectroscopic Process Analysis & RDF/SRF Control), an innovative inline solution for quality control of alternative fuels in the cement industry. The system will be presented at the Global CemFuels Conference 2026 in Geneva on September 23 and 24, 2026. Jena, Germany | ZEISS Group ZEISS SPARC continuously determines the […]

Newly-created Chief Technology Officer role marks a new chapter for bit.bio as the company expands its leadership team and technology portfolio The ioScreen platform enables pharmaceutical, biotechnology and in silico companies to access industrial-scale CRISPR screening in human stem cell-derived models without building specialist in-house capabilities Service gives researchers a more physiologically relevant way to […]

CHO.SET® 2.0 library of synthetic promoters provide tuneable expression of transgenes whilst maximising CHO cell productivity CHO.SET® promoters enable higher protein titres, reduced costs and shorter development timelines Sheffield, UK: SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the introduction of […]

CAMBRIDGE, Mass. — Elemental Machines, a pioneer in life sciences operational intelligence, today announced the launch of Resources Manager, its asset intelligence platform, designed to enable life sciences teams to move beyond simple asset monitoring and manage the operational context around their equipment, locations, schedules, and records. Resources is designed to work alongside existing enterprise asset management systems […]

Nature Communications study finds UNCOVERseq™ delivered the strongest combined sensitivity and precision among evaluated CRISPR off-target nomination methods Findings provide a more rigorous framework for prioritizing potential off-target sites for confirmation and safety assessment in CRISPR-based therapeutic development, supporting more confident progress from promising science toward responsible therapeutic impact Study defines sequencing, replication and process-control conditions […]